Comparing trastuzumab to bevacizumab for the treatment of breast cancer
Zoledronate versus ibandronate for the treatment of breast cancer
Anastrozole versus tamoxifen for the treatment of breast cancer
Letrozole versus tamoxifen for treating breast cancer
Letrozole versus anastrozole for treating breast cancer
Accelerated approval for new cancer drugs
Vemurafenib (formerly PLX4032) for treating metastatic melanoma. Find one randomized control trial comparing this drug to another drug. For your second article, find an article testing PLX4032 on cancer cell lines. Choose a review article of your choice.
Crizotinib for treating non-small cell lung cancer. See H. McEwen about the choosing your articles.
Melanoma
Ipilimumab and sargramostim compared to ipilimumab for treating metastatic melanoma
Nivolumab vs ipilimumab for treating melanoma
Nivolumab vs Ipilimumab vs Nivolumab and Ipilimumab for treating advanced melanoma
Vemurafenib vs dabrafenib vs trametinib for treating metastatic melanoma
Lung cancer
Comparing gefitinib versus docetaxel in treating non-small-cell lung cancer
Comparing vorinostat/paclitaxel to paclitaxel alone for treating non-small-cell lung cancer
Comparing vorinostat/carboplatin to carboplatin alone for treating non-small-cell lung cancer
Comparing atezolizumab to docetaxel for patients for treating non-small-cell lung cancer
Comparing nivolumab to docetaxel for treating non-small-cell lung cancer
Comparing atezolizumab and docetaxel for treatment of non-small cell lung cancer
Misc. oncology topics
Denosumab versus zoledronic acid for treating bone metastases in advanced cancer
Comparing adjuvant sunitinib to sorafenib for treating non-metastatic renal-cell carcinoma
Temozolomide vs. Standard PCV for treating high-grade gliomas
Comparing the pain intensity and misconceptions among hospice patients with cancer and their caregivers
Eicosapentaenoic acid versus aspirin for the prevention of colorectal adenomas